Drs. Sherr, Volgamier, and Simmons discuss using Ampyra to mitigate cognitive disability for patient with a VAMP2 gene mutation: Genetic Testing Leads to 'Awakening' for Dvelopmentally Delayed, 'Nearly Catatonic' Teen
Drs. Sherr, Volgamier, and Simmons discuss using Ampyra to mitigate cognitive disability for patient with a VAMP2 gene mutation: Genetic Testing Leads to 'Awakening' for Dvelopmentally Delayed, 'Nearly Catatonic' Teen